title: [Methylnaltrexone. A new approach for therapy of opioid-induced obstipation].
abstract: Chronic pain patients using opioids frequently suffer from constipation which compromises well-being. Such an opioid-induced gastro-intestinal complication can occur regularly in patients in palliative care as well as in analgesic sedated intensive care patients or during prolonged perioperative pain therapy. Discomfort and distress in the affected patients can be so severely pronounced that they would rather suffer from the pain than from the side effect of constipation. Conventional therapy can be insufficient in providing satisfactory relief of constipation, mostly because this opioid-induced bowel hypomotility can be laxative-resistant. Moreover, constipation does not decrease during the course of therapy as do other side effects. It is well known that opioid-induced constipation is mediated via activation of micro-opioid receptors in the gastrointestinal tract. Selective peripheral micro-receptor antagonists (such as methylnaltrexone, Relistor) can effectively treat opioid-induced constipation. An interference with central analgesia does not occur as the molecules cannot pass the blood-brain barrier due to their charged states. A reduction of opioid therapy or the development of withdrawal symptoms can be avoided. Studies have shown that methylnaltrexone is not only safe and efficient for chronically constipated palliative care patients but offers promising therapeutic options for further patient collectives.
authors.affiliation: Klinik für Anaesthesiologie, Ludwig-Maximilians-Universität, Nussbaumstr. 20, 80336 München. daniel.chappell@med.uni-muenchen.de
authors.forename: D
authors.initials: D
authors.lastname: Chappell
authors.forename: P
authors.initials: P
authors.lastname: Conzen
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D003248:Constipation / Q000139:chemically induced* / Q000188:drug therapy*; D003422:Critical Care; D006801:Humans; D009271:Naltrexone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D010166:Palliative Care; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D000644:Quaternary Ammonium Compounds; C032257:methylnaltrexone; D009271:Naltrexone
references.citation: Br J Anaesth. 2003 Dec;91(6):815-9
references.pmid: 14633751
references.citation: Gerontol Clin (Basel). 1969;11(3):137-44
references.pmid: 5770790
references.citation: J Pain Symptom Manage. 2002 Jan;23(1):48-53
references.pmid: 11779668
references.citation: Schmerz. 2005 Jun;19(3):214-9
references.pmid: 15004747
references.citation: BMJ. 2001 May 12;322(7295):1154-8
references.pmid: 11348910
references.citation: Anesth Analg. 2004 Feb;98(2):364-370
references.pmid: 14742371
references.citation: Am J Hosp Palliat Care. 2005 Sep-Oct;22(5):375-81
references.pmid: 16225360
references.citation: JAMA. 2000 Sep 20;284(11):1383-4
references.pmid: 10989399
references.citation: J Clin Oncol. 2001 May 1;19(9):2542-54
references.pmid: 11331334
references.citation: Pain. 1999 Mar;80(1-2):215-28
references.pmid: 10204734
references.citation: Curr Opin Support Palliat Care. 2007 Aug;1(2):117-25
references.pmid: 18685352
references.citation: Support Care Cancer. 2008 May;16(5):453-9
references.pmid: 18197439
references.citation: Drugs. 2003;63(7):649-71
references.pmid: 12656645
references.citation: Support Care Cancer. 2003 Nov;11(11):679-85
references.pmid: 14505158
references.citation: J Pharmacol Exp Ther. 1990 May;253(2):784-90
references.pmid: 2160010
references.citation: N Engl J Med. 2008 May 29;358(22):2332-43
references.pmid: 18509120
references.citation: Neuropharmacology. 1999 Mar;38(3):425-32
references.pmid: 10219980
references.citation: Ann Pharmacother. 2007 Jun;41(6):984-93
references.pmid: 17504835
references.citation: Trends Neurosci. 2000 Sep;23(9):436-42
references.pmid: 10941194
references.citation: Wien Med Wochenschr. 2008;158(21-22):621-6
references.pmid: 19052708
references.citation: BMC Gastroenterol. 2006 Jun 22;6:19
references.pmid: 16792799
references.citation: Gut. 1999 Sep;45 Suppl 2:II43-7
references.pmid: 10457044
references.citation: Crit Care. 2008;12(4):161
references.pmid: 18598388
references.citation: J Support Oncol. 2009 Jan-Feb;7(1):39-46
references.pmid: 19278178
references.citation: J Clin Oncol. 1992 Jan;10(1):149-55
references.pmid: 1345797
references.citation: Nat Med. 2003 Aug;9(8):1003-8
references.pmid: 12894165
references.citation: Eur J Pain. 2009 Jan;13(1):56-64
references.pmid: 18762438
references.citation: Schmerz. 2005 Oct;19(5):447-52, 454-5
references.pmid: 16133300
references.citation: Palliat Med. 1998 Sep;12(5):375-82
references.pmid: 9924600
references.citation: J Pain Symptom Manage. 1998 Oct;16(4):240-4
references.pmid: 9803051
references.citation: Science. 2001 Jul 13;293(5528):311-5
references.pmid: 11452128
references.citation: Palliat Med. 2006 Jun;20(4):419-23
references.pmid: 16875112
references.citation: Palliat Med. 2000 Mar;14(2):111-9
references.pmid: 10829145
references.citation: Clin Pharmacol Ther. 2001 Jan;69(1):66-71
references.pmid: 11180040
references.citation: Arthritis Res Ther. 2005;7(5):R1046-51
references.pmid: 16207320
references.citation: Pain Physician. 2007 Mar;10(2):357-66
references.pmid: 17387357
references.citation: Am J Surg. 2001 Nov;182(5A Suppl):11S-18S
references.pmid: 11755892
references.citation: J Pain Symptom Manage. 1998 Jan;15(1):1-7
references.pmid: 9436336
references.citation: Intensive Care Med. 2006 Jun;32(6):875-80
references.pmid: 16715327
references.citation: J Physiol Pharmacol. 2004 Mar;55(1 Pt 2):279-88
references.pmid: 15082884
references.citation: J Pain Symptom Manage. 2000 Jul;20(1):19-26
references.pmid: 10946165
references.citation: J Palliat Care. 1991 Winter;7(4):5-8
references.pmid: 1783966
references.citation: Int J Clin Pract. 2007 Jul;61(7):1181-7
references.pmid: 17488292
references.citation: J Clin Pharmacol. 2005 May;45(5):538-46
references.pmid: 15831777
references.citation: J Pain Symptom Manage. 2008 Jan;35(1):103-13
references.pmid: 17981003
references.citation: Expert Opin Investig Drugs. 2006 May;15(5):541-52
references.pmid: 16634692